Drug Profile
EBC 1013
Alternative Names: EBC-1013; WH-1 - QBiotics; WH1Latest Information Update: 06 Sep 2023
Price :
$50
*
At a glance
- Originator QBiotics
- Class Skin disorder therapies; Small molecules
- Mechanism of Action Cell movement activators; Signal transduction pathway stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I/II Leg ulcer
- Preclinical Wounds